Skip to main content
Equibles

HHLR ADVISORS, LTD.

Position in ALGS — Aligos Therapeutics, Inc.

CIK 1762304 GRAND CAYMAN, E9
Back to ALGS Full portfolio

Position in ALGS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$439,945
-$126,570 QoQ
Shares Held
76,247
0.0% QoQ
Ownership
2.13%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#8
of 31 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ALGS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HHLR ADVISORS, LTD. holds $365,309,791 across 9 Biotechnology names. ALGS ranks #9 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LEGN
Legend Biotech Corp
 5,984,550 $172,833,804
2 AVBP
ArriVent BioPharma, Inc.
 3,929,117 $136,497,524
3 ODTX
Odyssey Therapeutics, Inc.
 831,656 $15,560,283
4 NBP
NovaBridge Biosciences
 5,980,568 $11,662,107
5 CTNM
Contineum Therapeutics, Inc.
 669,337 $10,970,433
6 MAZE
Maze Therapeutics, Inc.
 366,028 $10,922,275
7 SGMT
Sagimet Biosciences Inc.
 724,800 $5,602,704
8 GOSS
Gossamer Bio, Inc.
 62,176 $820,716

All Filings in ALGS

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $439,945 76,247
2026-03-31 $566,515 76,247
2025-12-31 $710,622 76,247
2025-09-30 $747,220 76,247
2025-06-30 $549,740 76,247
2025-03-31 $629,037 76,247
2024-12-31 $3,037,680 76,247
2024-09-30 $660,299 76,247
2024-06-30 $1,092,591 3,121,689
2024-03-31 $1,868,067 1,906,191
2023-12-31 $1,265,710 1,906,191
2023-09-30 $1,725,393 2,309,764
2023-06-30 $2,242,780 2,309,764
2023-03-31 $2,018,733 2,309,764
2022-12-31 $2,201,205 2,309,764
2022-09-30 $2,601,570 2,365,064
2022-06-30 $2,861,727 2,365,064
2022-03-31 $5,084,887 2,365,064
2021-12-31 $28,073,309 2,365,064
2021-09-30 $36,682,142 2,365,064
2021-06-30 $44,134,829 2,165,064
2021-03-31 $49,233,555 2,165,064
2020-12-31 $59,864,019 2,165,064